Your browser doesn't support javascript.
loading
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients.
Mariani, Stefano; Puzzoni, Marco; Giampieri, Riccardo; Ziranu, Pina; Pusceddu, Valeria; Donisi, Clelia; Persano, Mara; Pinna, Giovanna; Cimbro, Erika; Parrino, Alissa; Spanu, Dario; Pretta, Andrea; Lai, Eleonora; Liscia, Nicole; Lupi, Alessio; Giglio, Enrica; Palomba, Grazia; Casula, Milena; Pisano, Marina; Palmieri, Giuseppe; Scartozzi, Mario.
  • Mariani S; Azienda Ospedaliera Universitaria (AOU) Cagliari, University Hospital and University of Cagliari, Cagliari, Italy.
  • Puzzoni M; Azienda Ospedaliera Universitaria (AOU) Cagliari, University Hospital and University of Cagliari, Cagliari, Italy.
  • Giampieri R; Medical Oncology Unit, University Hospital and Università Politecnica delle Marche, Ancona, Italy.
  • Ziranu P; Azienda Ospedaliera Universitaria (AOU) Cagliari, University Hospital and University of Cagliari, Cagliari, Italy.
  • Pusceddu V; Azienda Ospedaliera Universitaria (AOU) Cagliari, University Hospital and University of Cagliari, Cagliari, Italy.
  • Donisi C; Azienda Ospedaliera Universitaria (AOU) Cagliari, University Hospital and University of Cagliari, Cagliari, Italy.
  • Persano M; Azienda Ospedaliera Universitaria (AOU) Cagliari, University Hospital and University of Cagliari, Cagliari, Italy.
  • Pinna G; Azienda Ospedaliera Universitaria (AOU) Cagliari, University Hospital and University of Cagliari, Cagliari, Italy.
  • Cimbro E; Azienda Ospedaliera Universitaria (AOU) Cagliari, University Hospital and University of Cagliari, Cagliari, Italy.
  • Parrino A; Azienda Ospedaliera Universitaria (AOU) Cagliari, University Hospital and University of Cagliari, Cagliari, Italy.
  • Spanu D; Azienda Ospedaliera Universitaria (AOU) Cagliari, University Hospital and University of Cagliari, Cagliari, Italy.
  • Pretta A; Azienda Ospedaliera Universitaria (AOU) Cagliari, University Hospital and University of Cagliari, Cagliari, Italy.
  • Lai E; Azienda Ospedaliera Universitaria (AOU) Cagliari, University Hospital and University of Cagliari, Cagliari, Italy.
  • Liscia N; Azienda Ospedaliera Universitaria (AOU) Cagliari, University Hospital and University of Cagliari, Cagliari, Italy.
  • Lupi A; Medical Oncology Unit, University Hospital and Università Politecnica delle Marche, Ancona, Italy.
  • Giglio E; Medical Oncology Unit, University Hospital and Università Politecnica delle Marche, Ancona, Italy.
  • Palomba G; Unit of Cancer Genetics and Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Sassari, Italy.
  • Casula M; Unit of Cancer Genetics and Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Sassari, Italy.
  • Pisano M; Unit of Cancer Genetics and Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Sassari, Italy.
  • Palmieri G; Unit of Cancer Genetics and Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Sassari, Italy.
  • Scartozzi M; Azienda Ospedaliera Universitaria (AOU) Cagliari, University Hospital and University of Cagliari, Cagliari, Italy.
Front Oncol ; 12: 852583, 2022.
Article en En | MEDLINE | ID: mdl-35530345
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2022 Tipo del documento: Article